SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
1.070
-0.035 (-3.17%)
At close: Feb 21, 2025, 4:00 PM
1.079
+0.009 (0.87%)
After-hours: Feb 21, 2025, 5:26 PM EST
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $40.61 million as of February 21, 2025. Its market cap has decreased by -45.28% in one year.
Market Cap
40.61M
Enterprise Value
-12.32M
1-Year Change
-45.28%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $40.61M, a decrease of -46.64%. That is a compound annual growth rate of -5.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 40.60M | -11.55% |
| Dec 31, 2024 | 45.90M | -44.70% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |